Live from the NIH registry
Studies recruiting near Oceanside right now
Top 25 of 707 recruiting studies, sorted by proximity — each links to its official registry page
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Melanoma Stage III, Melanoma Stage IV
Phase 2
Interventional 25 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: University of California, San Francisco
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — La Jolla, California (26.2 mi)
· Sponsor: AstraZeneca
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Headlands Research California, LLC — Escondido, California (14.8 mi)
· Sponsor: Medtronic MiniMed, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-San Marcos — San Marcos, California (10.0 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
The Neurology Center of Southern California - Carlsbad Office — La Jolla, California (26.2 mi)
· Sponsor: AbbVie
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
Allergic Reactions
Phase 4
Interventional 600 participants sought
Orso Health, Inc. — La Jolla, California (26.2 mi)
· Sponsor: ARS Pharmaceuticals, Inc.
Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
Belly Pain, GI Health
N/A
Interventional 825 participants sought
Radicle Science Inc. — Del Mar, California (18.5 mi)
· Sponsor: Radicle Science
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
University of California, San Diego — La Jolla, California (26.2 mi)
· Sponsor: Guardant Health, Inc.
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Hepatocellular Carcinoma
Phase 1, Phase 2
Interventional 304 participants sought
Research Site — La Jolla, California (26.2 mi)
· Sponsor: AstraZeneca
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
UCSD Health La Jolla — La Jolla, California (26.2 mi)
· Sponsor: Joseph Broderick, MD
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Rady Children's Hospital, UCSD — La Jolla, California (26.2 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Amyloidosis, Amyloid Cardiomyopathy
Phase 3
Interventional 587 participants sought
University of California, San Diego (UCSD) - Medical Center — La Jolla, California (26.2 mi)
· Sponsor: Eidos Therapeutics, a BridgeBio company
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Phase 3
Interventional 160 participants sought
Excell Research Inc — Oceanside, California (4.6 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Excell Research /ID# 270258 — Oceanside, California (4.6 mi)
· Sponsor: AbbVie
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 300 participants sought
Moores Cancer Center - UCSD Health — La Jolla, California (26.2 mi)
· Sponsor: Surgimab
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Moores Cancer Center ( Site 0003) — La Jolla, California (26.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-San Marcos — San Marcos, California (10.0 mi)
· Sponsor: NRG Oncology
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Heart Transplant, Heart Failure
N/A
Interventional 60 participants sought
UC San Diego Health — La Jolla, California (26.2 mi)
· Sponsor: XVIVO Perfusion
[18F]PI-2620 Phase 3 Histopathological Study
Alzheimer Disease
Phase 3
Interventional 200 participants sought
Esperanza Clinical — Murrieta, California (23.4 mi)
· Sponsor: Lantheus Biosciences Ltd.
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
Phase 3
Interventional 800 participants sought
Research Site — La Jolla, California (26.2 mi)
· Sponsor: AstraZeneca
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Profound Research LLC ( Site 0105) — Oceanside, California (4.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Relapsed Refractory Multiple Myeloma
Phase 3
Interventional 508 participants sought
Research Site — La Jolla, California (26.2 mi)
· Sponsor: AstraZeneca
Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis
Early Psychosis
Phase 3
Interventional 120 participants sought
UC San Diego — La Jolla, California (26.2 mi)
· Sponsor: University of California, San Diego
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Solid Tumor, Adult, Colorectal Cancer
Phase 1, Phase 2
Interventional 240 participants sought
UCSD Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: A2 Biotherapeutics Inc.
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Bacterial Conjunctivitis
Phase 3
Interventional 400 participants sought
Baxis Site 19 — La Jolla, California (26.2 mi)
· Sponsor: Baxis Pharmaceuticals, Inc.